Search Results

Filter
  • 1-10 of  998 results for ""Scleroderma, Systemic""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

The association of outdoor temperature and self-reported Raynaud's phenomenon severity among people with systemic sclerosis: a Scleroderma Patient-centered Intervention Network Cohort study.

Subjects: Raynaud Disease*/Raynaud Disease*/Raynaud Disease*/epidemiology ; Raynaud Disease*/Raynaud Disease*/Raynaud Disease*/etiology ; Scleroderma, Systemic*/Scleroderma, Systemic*/Scleroderma, Systemic*/complications

  • Source: The Lancet. Rheumatology [Lancet Rheumatol] 2024 Oct; Vol. 6 (10), pp. e684-e692. Date of Electronic Publication: 2024 Aug 28.Publisher: Elsevier Ltd Country of Publication: England NLM ID: 101765308 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Outdoor temperatures and Raynaud's phenomenon in patients with systemic sclerosis.

  • Authors : Cutolo M; Laboratory of Experimental Rheumatology and Academic Division of Clinical Rheumatology, Department of Internal Medicine, University of Genova, 16132 Genoa, Italy; University of Genova, 16132 Genoa, Italy

Subjects: Raynaud Disease*/Raynaud Disease*/Raynaud Disease*/diagnosis ; Raynaud Disease*/Raynaud Disease*/Raynaud Disease*/etiology ; Scleroderma, Systemic*/Scleroderma, Systemic*/Scleroderma, Systemic*/complications

  • Source: The Lancet. Rheumatology [Lancet Rheumatol] 2024 Oct; Vol. 6 (10), pp. e655-e657. Date of Electronic Publication: 2024 Aug 28.Publisher: Elsevier Ltd Country of Publication: England NLM ID: 101765308 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Increased angiopoietin-1 improves nailfold capillary morphology in patients with systemic sclerosis.

  • Authors : Shima Y; Laboratory of Thermo-therapeutics for Vascular Dysfunction, Osaka University Graduate School of Medicine, Suita, Japan. Electronic address: .; Watanabe A

Subjects: Microscopic Angioscopy* ; Angiopoietin-1*/Angiopoietin-1*/Angiopoietin-1*/blood ; Scleroderma, Systemic*/Scleroderma, Systemic*/Scleroderma, Systemic*/blood

  • Source: Microvascular research [Microvasc Res] 2025 Jan; Vol. 157, pp. 104761. Date of Electronic Publication: 2024 Nov 07.Publisher: Academic Press Country of Publication: United States NLM ID: 0165035 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Capillaroscopy in the daily clinic of the pediatric rheumatologist.

  • Authors : Schonenberg-Meinema D; Department of Pediatric Immunology, Rheumatology and Infectious Diseases, Emma Children's Hospital, Amsterdam University Medical Centers, University of Amsterdam, the Netherlands. Electronic address: .; Cutolo M

Subjects: Microscopic Angioscopy*/Microscopic Angioscopy*/Microscopic Angioscopy*/methods ; Raynaud Disease*/Raynaud Disease*/Raynaud Disease*/diagnosis ; Raynaud Disease*/Raynaud Disease*/Raynaud Disease*/physiopathology Juvenile systemic scleroderma; Juvenile-onset scleroderma

  • Source: Best practice & research. Clinical rheumatology [Best Pract Res Clin Rheumatol] 2024 Sep; Vol. 38 (3), pp. 101978. Date of Electronic Publication: 2024 Jul 20.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101121149 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Long-Term Data on Efficacy and Safety of Selexipag for Digital Systemic Sclerosis Vasculopathy.

  • Authors : Di Battista M; M. Di Battista, MD, Rheumatology Unit, University of Pisa, Pisa, and Department of Medical Biotechnologies, University of Siena, Siena; .

Subjects: Scleroderma, Systemic*/Scleroderma, Systemic*/Scleroderma, Systemic*/drug therapy ; Scleroderma, Systemic*/Scleroderma, Systemic*/Scleroderma, Systemic*/complications ; Raynaud Disease*/Raynaud Disease*/Raynaud Disease*/drug therapy

  • Source: The Journal of rheumatology [J Rheumatol] 2024 Sep 01; Vol. 51 (9), pp. 899-903. Date of Electronic Publication: 2024 Sep 01.Publisher: Journal Of Rheumatology Publishing Co Country of Publication: Canada NLM ID: 7501984 Publication Model: Electronic Cited Medium: Internet

Record details

×
Editorial & Opinion

No seasonal trends in referrals for vascular investigations: insight into the diagnosis of Raynaud's phenomenon and systemic sclerosis.

  • Authors : Dinsdale G; Department of Rheumatology, Salford Care Organisation, Northern Care Alliance NHS Foundation Trust, Salford, UK.; Mandzuk M

Subjects: Raynaud Disease*/Raynaud Disease*/Raynaud Disease*/diagnosis ; Raynaud Disease*/Raynaud Disease*/Raynaud Disease*/epidemiology ; Scleroderma, Systemic*/Scleroderma, Systemic*/Scleroderma, Systemic*/diagnosis

  • Source: Clinical and experimental rheumatology [Clin Exp Rheumatol] 2024 Aug; Vol. 42 (8), pp. 1699-1700. Date of Electronic Publication: 2024 Aug 02.Publisher: Clinical And Experimental Rheumatology S.A.S Country of Publication: Italy NLM ID: 8308521 Publication Model: Print-Electronic Cited Medium:

Record details

×
Report

Raynaud's of the gut? Systemic sclerosis-associated microvascular ischaemic colitis responsive to intravenous iloprost.

  • Authors : Pratap K; Department of Gastroenterology, St Vincent's Hospital, Sydney, NSW, Australia.; Penglase R

Subjects: Iloprost*/Iloprost*/Iloprost*/therapeutic use ; Iloprost*/Iloprost*/Iloprost*/administration & dosage ; Raynaud Disease*/Raynaud Disease*/Raynaud Disease*/drug therapy

  • Source: Rheumatology (Oxford, England) [Rheumatology (Oxford)] 2024 Aug 01; Vol. 63 (8), pp. e219-e221.Publisher: Oxford University Press Country of Publication: England NLM ID: 100883501 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Editorial & Opinion

Nailfold capillary abnormalities are associated with increased severity of Raynaud phenomenon among patients with systemic sclerosis: a pilot study.

  • Authors : Lau CB; Department of Dermatology, Massachusetts General Hospital, Boston, MA, USA.; Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA.

Subjects: Raynaud Disease*/Raynaud Disease*/Raynaud Disease*/complications ; Scleroderma, Systemic*/Scleroderma, Systemic*/Scleroderma, Systemic*/complications ; Scleroderma, Systemic*/Scleroderma, Systemic*/Scleroderma, Systemic*/pathology

  • Source: Clinical and experimental dermatology [Clin Exp Dermatol] 2024 Jul 19; Vol. 49 (8), pp. 912-913.Publisher: Oxford University Press Country of Publication: England NLM ID: 7606847 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

2023 Brazilian Society of Rheumatology guidelines for the treatment of systemic sclerosis.

  • Authors : Kayser C; Rheumatology Division, Escola Paulista de Medicina, Universidade Federal de São Paulo-UNIFESP, Rua dos Otonis 863, 2º andar, Vila Clementino, São Paulo, SP, 04025-002, Brazil. .; de Oliveira Delgado SM

Subjects: Scleroderma, Systemic*/Scleroderma, Systemic*/Scleroderma, Systemic*/complications ; Scleroderma, Systemic*/Scleroderma, Systemic*/Scleroderma, Systemic*/drug therapy ; Rheumatology*/Rheumatology*/Rheumatology*/standards

  • Source: Advances in rheumatology (London, England) [Adv Rheumatol] 2024 Jul 10; Vol. 64 (1), pp. 52. Date of Electronic Publication: 2024 Jul 10.Publisher: BioMed Central Country of Publication: England NLM ID: 101734172 Publication Model: Electronic Cited Medium: Internet ISSN: 2523-3106

Record details

×
Academic Journal

Heating of the neck or elbows alleviates Raynaud's phenomenon but has different effects on different types of patients with systemic sclerosis.

  • Authors : Shima Y; Laboratory of Thermo-therapeutics for Vascular Dysfunction, Osaka University Graduate School of Medicine, Suita, Japan.; Department of Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, Suita, Japan.

Subjects: Raynaud Disease*/Raynaud Disease*/Raynaud Disease*/drug therapy ; Scleroderma, Systemic*/Scleroderma, Systemic*/Scleroderma, Systemic*/complications ; Scleroderma, Systemic*/Scleroderma, Systemic*/Scleroderma, Systemic*/drug therapy

  • Source: Modern rheumatology [Mod Rheumatol] 2024 Jul 06; Vol. 34 (4), pp. 750-755.Publisher: Oxford University Press Country of Publication: England NLM ID: 100959226 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
  • 1-10 of  998 results for ""Scleroderma, Systemic""